OLEMA PHARMACEUTICALS INC (OLMA) Institutional Ownership Changes & 13F Activity
OLEMA PHARMACEUTICALS INC (OLMA). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Bain Capital Life Sciences Investors, Llc, Paradigm Biocapital Advisors Lp, Janus Henderson Group Plc, Bvf Inc/Il, and Fmr Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Catalio Capital Management, Lp | Buy | +267,058 | — | 267,058 | $6.68M | Q4 2025 | Sep 02, 2026 |
| Virtu Financial Llc | Buy | +42,437 | — | 42,437 | $1.06M | Q4 2025 | Feb 23, 2026 |
| Ikarian Capital, Llc | Buy | +758,654 | — | 758,654 | $18.97M | Q4 2025 | Feb 18, 2026 |
| Raymond James Financial Inc | Buy | +40,647 | — | 40,647 | $1.02M | Q4 2025 | Feb 18, 2026 |
| Ep Wealth Advisors, Llc | Buy | +10,009 | — | 10,009 | $250.22K | Q4 2025 | Feb 18, 2026 |
| Bain Capital Life Sciences Investors, Llc | Buy | +8,508,641 | — | 8,508,641 | $212.72M | Q4 2025 | Feb 17, 2026 |
| Paradigm Biocapital Advisors Lp | Buy | +7,544,172 | — | 7,544,172 | $188.60M | Q4 2025 | Feb 17, 2026 |
| Janus Henderson Group Plc | Buy | +6,710,194 | — | 6,710,194 | $167.90M | Q4 2025 | Feb 17, 2026 |
| Bvf Inc/Il | Buy | +5,295,893 | — | 5,295,893 | $132.40M | Q4 2025 | Feb 17, 2026 |
| Fmr Llc | Buy | +5,023,092 | — | 5,023,092 | $125.58M | Q4 2025 | Feb 17, 2026 |
| Logos Global Management Lp | Buy | +3,208,875 | — | 3,208,875 | $80.22M | Q4 2025 | Feb 17, 2026 |
| Cormorant Asset Management, Lp | Buy | +2,750,000 | — | 2,750,000 | $68.75M | Q4 2025 | Feb 17, 2026 |
| Ra Capital Management, L.P. | Buy | +2,600,000 | — | 2,600,000 | $65.00M | Q4 2025 | Feb 17, 2026 |
| Lightspeed Management Company, L.L.C. | Buy | +1,930,894 | — | 1,930,894 | $48.27M | Q4 2025 | Feb 17, 2026 |
| Vestal Point Capital, Lp | Buy | +1,650,000 | — | 1,650,000 | $41.25M | Q4 2025 | Feb 17, 2026 |
| Woodline Partners Lp | Buy | +1,481,930 | — | 1,481,930 | $37.05M | Q4 2025 | Feb 17, 2026 |
| Polar Capital Holdings Plc | Buy | +1,380,450 | — | 1,380,450 | $34.51M | Q4 2025 | Feb 17, 2026 |
| Citadel Advisors Llc | Buy | +1,200,307 | — | 1,200,307 | $30.01M | Q4 2025 | Feb 17, 2026 |
| Price T Rowe Associates Inc | Buy | +1,096,035 | — | 1,096,035 | $27.40M | Q4 2025 | Feb 17, 2026 |
| Samlyn Capital, Llc | Buy | +1,069,543 | — | 1,069,543 | $26.74M | Q4 2025 | Feb 17, 2026 |
| Kingdon Capital Management, L.L.C. | Buy | +953,600 | — | 953,600 | $23.84M | Q4 2025 | Feb 17, 2026 |
| Holocene Advisors, Lp | Buy | +506,001 | — | 506,001 | $12.65M | Q4 2025 | Feb 17, 2026 |
| Millennium Management Llc | Buy | +498,490 | — | 498,490 | $12.46M | Q4 2025 | Feb 17, 2026 |
| Northern Trust Corp | Buy | +445,327 | — | 445,327 | $11.13M | Q4 2025 | Feb 17, 2026 |
| Two Sigma Investments, Lp | Buy | +393,658 | — | 393,658 | $9.84M | Q4 2025 | Feb 17, 2026 |
| Point72 Asset Management, L.P. | Buy | +307,890 | — | 307,890 | $7.70M | Q4 2025 | Feb 17, 2026 |
| Highvista Strategies Llc | Buy | +241,489 | — | 241,489 | $6.04M | Q4 2025 | Feb 17, 2026 |
| Bank Of America Corp | Buy | +238,914 | — | 238,914 | $5.97M | Q4 2025 | Feb 17, 2026 |
| Wellington Management Group Llp | Buy | +220,971 | — | 220,971 | $5.52M | Q4 2025 | Feb 17, 2026 |
| Boothbay Fund Management, Llc | Buy | +219,086 | — | 219,086 | $5.48M | Q4 2025 | Feb 17, 2026 |
Frequently asked questions about OLMA activity
Which institutional owners are buying OLMA?
Institutional owners buying OLMA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in OLMA activity?
"Buy" means an investor increased their reported position in OLMA compared to the prior reporting period. This reflects growing exposure to OLEMA PHARMACEUTICALS INC (OLMA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in OLMA increasing?
Institutional interest in OLMA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related OLMA Institutional Insights
- OLMA Overview
- OLMA 13F Institutional Holders
- OLMA Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- OLMA Insider Trading & SEC Form 4 Activity
- OLMA Articles
- Top Institutional Investor Stock Rankings